"It's perceived as being a lesser problem in children," Bryant told Live Science. Across these germs, resistance rates were similar across high- and low-income countries in 2004, but those trends diverged by 2022. Overall, resistance to Access antibiotics declined across the study period, but that improvement wasn't the same across all settings. These trends were driven largely by increases in low-income settings, but high-income settings were not spared. "But it's the first large dataset, really, to look specifically at children," Bryant said.